Tretinoin is a first-generation retinoid and derivative of vitamin A that is primarily prescribed for the clinical management of acne vulgaris and acute promyelocytic leukemia. It functions as a potent… Read more




![Chemical structure of (2E,4E,6E)-3-Methyl-7-((8aR)-5,5,8a-trimethyloctahydrobenzo[c][1,2]dioxin-3-yl)octa-2,4,6-trienoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2E4E6E-3-Methyl-7-8aR-558a-trimethyloctahydrobenzoc12dioxin-3-ylocta-246-trienoic-Acid.png&w=3840&q=75)

![Chemical structure of (2E,4E,6E)-3-Methyl-7-(5,5,8a-trimethyl-3,5,6,7,8,8a-hexahydrobenzo[c][1,2]dioxin-3-yl)octa-2,4,6-trienoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F129454-96-2-2E4E6E-3-Methyl-7-558a-trimethyl-356788a-hexahydrobenzoc12dioxin-3-ylocta-246-trienoic-Acid.png&w=3840&q=75)











































Tretinoin is a first-generation retinoid and derivative of vitamin A that is primarily prescribed for the clinical management of acne vulgaris and acute promyelocytic leukemia. It functions as a potent modulator of gene expression by binding to retinoic acid receptors, thereby influencing critical biological processes such as cellular differentiation, proliferation, and apoptosis. To ensure the safety and efficacy of therapeutic formulations, pharmaceutical laboratories utilize highly characterized reference standards to support rigorous quality control and regulatory compliance. This category includes comprehensive materials such as process-related impurities, degradation products, and metabolites that are essential for accurate impurity profiling and analytical method validation. Additionally, the inclusion of stable isotope labelled compounds provides critical support for sensitive mass spectrometry applications, allowing for precise quantification and the establishment of robust, reproducible analytical benchmarks in compliance with international pharmacopeial standards.